health
Heart Rate Decrease
Adverse effectHeart Rate Decrease describes a reduction in how quickly the heart beats. It is an adverse health-related effect, meaning the outcome is treated as potentially undesirable rather than as a wellness benefit.
A focused look at Heart Rate Decrease as a health-related effect, helping clarify what this term describes.
These are research findings, not promises. Most options have little evidence, and results differ from person to person.
What can cause it
How likely each one is to cause it, most likely first.
AcupuncturepracticeUnclear
Based on one study. Strongest study: a pooled analysis of several trials.
A pooled analysis of randomized trials in 2026 reported bradycardia, or a slow heart rate.
Open the Acupuncture pageYogapracticeUnclear
Based on one study.
Slow yogic breathing and deep relaxation can raise vagal tone and lower heart rate. This is usually harmless, but people with a slow pulse or taking heart-rate-lowering drugs may feel dizzy or faint, mainly when standing up quickly.
Open the Yoga pageOzone TherapypracticeUnclear
Based on one study. Strongest study: a narrative review.
A 2022 review described a vagal crisis in people receiving treatment for Osteoarthritis or Rheumatoid Arthritis.
Open the Ozone Therapy page
The expert view shows every study, dose protocol and source.
What can cause it
Interventions reported to bring this on3 listedHighest probability
- →PracticesAcupunctureCertaintyLowSourceClinical1 other source
A pooled analysis of randomized trials in 2026 reported bradycardia, or a slow heart rate.
- →PracticesYogaCertaintyLowSourceReference knowledge1 other source
Slow yogic breathing and deep relaxation can raise vagal tone and lower heart rate. This is usually harmless, but people with a slow pulse or taking heart-rate-lowering drugs may feel dizzy or faint, mainly when standing up quickly.
Open YogaStudy result
Slow yogic breathing and deep relaxation raise vagal tone and lower the heart rate; usually harmless, but people with a slow pulse or on heart-rate-lowering drugs may feel dizzy or faint, mainly when standing up quickly.
- →PracticesOzone TherapyCertaintyLowSourceReview1 other source
A 2022 review described a vagal crisis in people receiving treatment for Osteoarthritis or Rheumatoid Arthritis.
Who was studied
- People with a condition
- Osteoarthritis
- Rheumatoid Arthritis
Open Ozone TherapyStudy result
Vagal crisis
How to read the evidence
Evidence tier — overall strength of the evidence for the whole compound
- StrongWell established — backed by strong, consistent human research.
- ModerateSome genuine support, but mostly from small or lower-quality studies. Promising, not proven.
- PreliminaryEarly-stage evidence — a promising hypothesis, not an established effect yet.
- LimitedVery limited evidence — treat this as a hypothesis, not proof.
- InsufficientNot enough good evidence to draw conclusions yet.
Certainty — how sure we can be that the effect is real
- Very highVery sure — strong, consistent evidence
- HighFairly sure — consistent evidence from good studies
- MediumModerately sure — new studies could change this
- LowNot sure — little or mixed evidence
- Very lowVery unsure — almost no usable evidence
Source — where the data comes from
- Meta-analysisPooled analysis of many trials — the strongest evidence
- RCTRandomized controlled trial — a strong human study design
- ClinicalA human clinical study
- Reference knowledgeFrom general health-science or pharmacology references, not a study of this exact claim
- Animal researchStudied in animals, not humans
- Community reportsAggregated user reports — anecdotal signal, not evidence
- TheoreticalMechanism-based reasoning, not yet tested
Study grade — quality of each underlying study (A best, D weakest)
- AHigh-quality — strong, consistent human trials
- BGood — solid evidence with some limitations
- CModerate — limited, small, or mixed-quality studies
- DWeak — preliminary, indirect, or animal-only
Confidence — how strongly the sources back a finding
A 0–100 score from study quality and agreement
Most supplement evidence is graded C–D. Read it as preliminary signal, not proof.
Full write-up
What is it
Heart Rate Decrease describes a reduction in how quickly the heart beats. It is an adverse health-related effect, meaning the outcome is treated as potentially undesirable rather than as a wellness benefit.
The term can refer to findings associated with different interventions, including Magnesium and Lavender Extract. Evidence does not apply uniformly across these examples: some findings come from human research, while others come from animal studies.
How interventions help
Interventions associated with a lower heart rate do not all act in the same way or have the same level of applicability. Some findings are consistent with direct rate-slowing cardiac effects, while others are described in terms of autonomic regulation or possible effects on cardiac ion channels. The possibility of additive effects is important: several entries specifically raise concern when an intervention is combined with medication or another substance that also slows heart rate, or in people who may be more susceptible.
Timing also differs. Some changes have been observed immediately or after an acute single dose, whereas others were assessed only after continued exposure over periods ranging from 2 weeks to 1 year. In the animal research, heart-rate changes were examined after 3, 7, or 14 days, which does not establish that the same pattern occurs in people. A lower heart rate is therefore not a uniform outcome: it may reflect a small measured shift, a potentially clinically meaningful response in a susceptible person, or an observation based mainly on pharmacology references or anecdotal reports. The human findings should be interpreted separately from animal, theoretical, and anecdotal evidence rather than treated as interchangeable.
Choosing guidance
Choice depends on whether you value direct human evidence, rapid observation, or broader synthesis across studies. Lavender Extract is the only option explicitly identified with human evidence and an immediate onset, so it may be most relevant when a quickly appearing, directly observed effect matters. Valerian Root represents an acute single-dose observation, while Omega-3 reflects repeated use over variable study periods; these findings should not be treated as interchangeable.
For evidence spanning multiple studies, Magnesium and Omega-3 are the options supported by meta-analyses. American Ginseng and Vitamin A have evidence from animal studies, which does not establish that the same effect occurs in people. Several other entries rely on pharmacology references, theoretical reasoning, or anecdotal reports rather than clinical study findings, so they are better viewed as possible effects than as confirmed human outcomes.
A cross-cutting consideration is susceptibility to a slower heart rate when an option is combined with another rate-slowing or cardiovascular agent; some entries also describe greater concern with higher amounts. The study-based entries do not flag conflicting evidence, but the absence of reported disagreement does not make animal, theoretical, or anecdotal findings equivalent to human clinical evidence. Options with rapid or acute observations may suit questions about short-term response, whereas options evaluated over longer periods are more relevant to repeated-use contexts.